Pidilite Industries Limited — Important, 22-01-2025: Updates

**Financial Highlights:**

For Q3 FY25, Pidilite Industries reported consolidated net sales of ₹3,357 Cr, reflecting a 9.3% year-on-year growth. EBITDA stood at ₹798 Cr (up 7.6%), while profit before tax (PBT) and profit after tax (PAT) rose to ₹752 Cr and ₹557 Cr, indicating increases of 7.5% and 9.4%, respectively. For the nine months of FY25, consolidated net sales reached ₹9,964 Cr, an increase of 5.5%, with EBITDA at ₹2,380 Cr, reflecting a notable growth of 11.8%.

**Strategic Initiatives and Growth Drivers:**

Pidilite is witnessing strong traction in its Business-to-Business (B2B) segment, with reported growth of 21.7% in the current quarter. Continuous investment in brands and the supply chain underscores its commitment to long-term growth.

**Business Developments:**

Domestic subsidiaries displayed robust performance, contributing to double-digit revenue growth with improved EBITDA margins. However, international subsidiaries, primarily due to geopolitical challenges, faced modest sales growth, excluding Pidilite USA and Pulvitec Brazil.

**Market Position and Competitive Advantage:**

The company is well-positioned, with its iconic brands like Fevicol and Dr. Fixit leading the market. The focus on innovation and effective marketing campaigns has solidified its competitive edge.

**Investor Implications:**

With a positive outlook driven by an anticipated demand uptick from improved construction activities and a strong market presence, investors should watch closely for further developments, as Pidilite continues to enhance its operational efficiencies and brand investments.